skip to main
|
skip to sidebar
Blog Archives: Nov 2004 - present
Special items: Ovarian Cancer and Us blog best viewed in Firefox
Editorial
Although safety and quality are acknowledged to be important and
although there has been some research in this area, in terms of the
pervasiveness of cancer and in relation to the tremendous amount of
cancer research performed every year, relatively little time and money
have been devoted to safety and quality. For example, I examined the
relative frequency of medical error research in cancer, as indexed by
PubMed. There are 2,822,819 human publications indexed under the search
terms “cancer” or “oncology,” 558,508 of which (20%) were published
within the last 5 years. When the term “medical errors” was included in
the search, a total of 687 articles were found, 270 of which (39%) were
published within the last 5 years. Of the articles published within the
last 5 years, 37 were reviews and 5 were clinical trials. The term
“medical errors” occurred in the title of only 1 review and 1 clinical
trial. In terms of relative frequencies, medical errors represented
0.024% of all cancer publications and, within the last 5 years, its
representation had doubled to 0.048%. This example does not represent
the entire literature regarding cancer safety and quality, but it does
suggest a relative paucity of publications in a critically important
area.
Furthermore, these studies must be published so that the entire cancer
community can benefit from their findings.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.